Compare ARK Genomic Revolution ETF (ARKG) vs Bank of Montreal (BMO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Bank of Montreal — how do they compare? ARK Genomic Revolution ETF trades at $41.35, while Bank of Montreal trades at $178.34 (market cap $125.01B). The key difference: Bank of Montreal pays a 2.77% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | BMO | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $43.57 | $178.96 |
52-Week Low | $23.09 | $110.44 |
Market Cap | — | $125.01B |
Dividend Yield | — | 2.77% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
BMO trades at $178.96, up 1.3% today, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a 34% YoY net income growth in Q2 2026 and a 25.92% net margin. Recent acquisitions and dividend increases highlight strategic growth, while analyst sentiment is balanced with 44% buy ratings. The company maintains robust cash flow and a solid balance sheet with $84.25B in equity.
Outlook remains positive driven by earnings beats and expansion in metals & mining. Risks include valuation concerns at a P/E of 19.51 and interest rate sensitivity. The stock offers a steady dividend yield, but investors should monitor integration of recent acquisitions and macroeconomic pressures on banking sectors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Bank of Montreal
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
Read more on BMO →
